Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Science|October 13, 2021
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicineYutaka Shimazu, Shohei Mizuno, Shin-Ichi Fuchida, et al.
International Journal of Hematology|November 16, 2018
Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphomaSatoshi Yamasaki, Dai Chihara, Sung-Won Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority TrialYoshinobu Kanda, Shun-Ichi Kimura, Masaki Iino, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 6, 2020
Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trialShun-Ichi Kimura, Yoshinobu Kanda, Masaki Iino, et al.
Scientific Reports|March 31, 2025
Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective studySatoshi Yamasaki, Masamitsu Yanada, Hiroaki Araie, et al.
European Journal of Clinical Pharmacology|October 29, 2015
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemiaYoji Ishida, Kazunori Murai, Kohei Yamaguchi, et al.
International Journal of Hematology|February 9, 2023
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALLYasushi Onishi, Eijiro Furukawa, Mayumi Kamata, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 31, 2024
Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphomaTatsuo Oyake, Takahiro Maeta, Takenori Takahata, et al.
Hematology (Amsterdam, Netherlands)|February 10, 2026
Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changesToshihiro Matsukawa, Shota Yoshida, Masahiro Onozawa, et al.
Hematology (Amsterdam, Netherlands)|April 16, 2024
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in JapanYoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, et al.
Pageof 4